News & Events
13 March 2020
COVID-19: On-hold status recruitment
Due to the COVID-19 pandemic, the patient recruitment for the EFFECT trial has been put on hold. All patients who were already included stopped exercising at a physiotherapy centre and will continue when they are allowed to. In the meantime, patients will perform home-based exercise.
 READ MORE
5 March 2020 - 6 March 2020
3rd Consortium Meeting in Gdańsk, Poland
This time, the consortium meeting took place at the Medical University of Gdańsk in Poland.
 READ MORE
5 September 2019 - 6 September 2019
2nd Consortium Meeting in Cologne, DE
The consortium met at the German Sport University Cologne to prepare the EFFECT and PERSPECTIVE studies.
 READ MORE
Collaboration

PREFERABLE consists of an international consortium of nine academic partners, one cutting edge game development and software engineering SME , one science-driven clinical trial management company and one European patient organisation (EUROPA DONNA – The European Breast Cancer Coalition, representing 47 countries throughout Europe). The partners are from seven countries in the Netherlands, Germany, Sweden, Poland, Spain, Italy and Australia and are coordinated by the University Medical Center Utrecht, the Netherlands.